• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD133与细胞核β-连环蛋白:检测低分期结直肠癌高危病例的标志物组合

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

作者信息

Horst David, Kriegl Lydia, Engel Jutta, Jung Andreas, Kirchner Thomas

机构信息

Pathologisches Institut der Ludwig-Maximilians-Universität München, Germany.

出版信息

Eur J Cancer. 2009 Jul;45(11):2034-40. doi: 10.1016/j.ejca.2009.04.004. Epub 2009 May 4.

DOI:10.1016/j.ejca.2009.04.004
PMID:19403300
Abstract

Nuclear beta-catenin and CD133 are linked with two hallmarks of colon cancer, wingless-type mouse mammary tumour virus integration site (WNT)-pathway dysregulation and colon cancer stem cells (Co-CSCs), respectively. Both molecules may be related, as Co-CSCs were proposed to require activated WNT-signalling and as CD133 was postulated as a WNT/beta-catenin target gene. Herein, we investigated the expression of these markers on serial sections of 162 stage IIA colonic adenocarcinomas. We found that the expression of these molecules is statistically independent and that they mark distinct but overlapping subpopulations of the tumour cells. Moreover, we show that their combined evaluation can identify colon cancer cases with vastly reduced survival (hazard ratio (HR) 13.4, 95% confidence interval (CI): 4.7-38.2) and a high risk of tumour progression (HR 6.8, 95%CI: 3.1-15.0). In conclusion, the independence of these markers may on the one hand have implications for their presumed value to identify Co-CSCs; on the other hand it allows their combined analysis to become a powerful tool to identify high risk cases of stage IIA colon cancer.

摘要

细胞核β-连环蛋白和CD133分别与结肠癌的两个特征相关,即无翅型小鼠乳腺肿瘤病毒整合位点(WNT)信号通路失调和结肠癌干细胞(Co-CSCs)。这两种分子可能有关联,因为有人提出Co-CSCs需要激活的WNT信号,且CD133被假定为WNT/β-连环蛋白靶基因。在此,我们研究了这两种标志物在162例IIA期结肠腺癌连续切片上的表达情况。我们发现这些分子的表达在统计学上相互独立,且它们标记了肿瘤细胞中不同但有重叠的亚群。此外,我们表明,联合评估它们能够识别出存活期大幅缩短(风险比(HR)13.4,95%置信区间(CI):4.7 - 38.2)且肿瘤进展风险高(HR6.8,95%CI:3.1 - 15.0)的结肠癌病例。总之,这些标志物的独立性一方面可能对它们在识别Co-CSCs方面的假定价值有影响;另一方面,这使得它们的联合分析成为识别IIA期结肠癌高危病例的有力工具。

相似文献

1
CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.CD133与细胞核β-连环蛋白:检测低分期结直肠癌高危病例的标志物组合
Eur J Cancer. 2009 Jul;45(11):2034-40. doi: 10.1016/j.ejca.2009.04.004. Epub 2009 May 4.
2
Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.原发性肺腺癌中潜在癌症干细胞标志物 CD133、CD44、ALDH1 和 β-连环蛋白的表达及其预后意义。
Pathol Int. 2012 Dec;62(12):792-801. doi: 10.1111/pin.12019.
3
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.EphA3 和 CD133 在结直肠癌中的表达的临床病理意义和预后价值。
J Clin Pathol. 2011 Jun;64(6):498-503. doi: 10.1136/jcp.2010.087213. Epub 2011 Mar 17.
4
Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.癌症干细胞标志物CD133、CD44和CD166在结直肠癌中的预后意义
Cancer Invest. 2009 Oct;27(8):844-50. doi: 10.1080/07357900902744502.
5
CD133 expression is an independent prognostic marker for low survival in colorectal cancer.CD133表达是结直肠癌患者低生存率的独立预后标志物。
Br J Cancer. 2008 Oct 21;99(8):1285-9. doi: 10.1038/sj.bjc.6604664. Epub 2008 Sep 9.
6
CD133 expression is correlated with poor prognosis in colorectal cancer.CD133表达与结直肠癌的不良预后相关。
Hepatogastroenterology. 2014 Sep;61(134):1563-7.
7
Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma.干细胞标志物Epcam和CD133表达对胆囊腺癌的预后价值
Hepatogastroenterology. 2014 May;61(131):574-9.
8
The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.WNT 通路在结直肠癌手术治疗中的预后意义:β-连环蛋白表达预测无病生存。
Anticancer Res. 2013 Oct;33(10):4573-84.
9
Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer.癌症干细胞标志物与结直肠癌的远处血行性肝转移相关,但与腹膜播散无关。
Cancer Invest. 2015;33(8):354-60. doi: 10.3109/07357907.2015.1047507. Epub 2015 Jun 12.
10
AC133 expression associated with poor prognosis in stage II colorectal cancer.AC133 的表达与 II 期结直肠癌的不良预后相关。
Med Oncol. 2013 Mar;30(1):356. doi: 10.1007/s12032-012-0356-z. Epub 2013 Jan 16.

引用本文的文献

1
GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.GART 在 RUVBL1/β-连环蛋白信号通路中作为一种新型甲基转移酶促进结直肠癌的肿瘤干性。
Adv Sci (Weinh). 2023 Sep;10(25):e2301264. doi: 10.1002/advs.202301264. Epub 2023 Jul 13.
2
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling.依米丁在乳腺癌细胞中作为 Wnt/β-连环蛋白信号通路的拮抗剂发挥抗癌活性。
Oncol Rep. 2019 Nov;42(5):1735-1744. doi: 10.3892/or.2019.7290. Epub 2019 Aug 22.
3
Effect of Shogaol on the Expression of Intestinal Stem Cell Markers in Experimentally Induced Colitis in BALB/c Mice.
姜烯酚对 BALB/c 小鼠实验性结肠炎肠干细胞标志物表达的影响。
Anal Cell Pathol (Amst). 2019 Mar 6;2019:5134156. doi: 10.1155/2019/5134156. eCollection 2019.
4
CD133 as a regulator of cancer metastasis through the cancer stem cells.CD133 通过肿瘤干细胞调节癌症转移。
Int J Biochem Cell Biol. 2019 Jan;106:1-7. doi: 10.1016/j.biocel.2018.10.013. Epub 2018 Nov 3.
5
Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.使用免疫组织化学检测乙醛脱氢酶 1A1(ALDH1A1)在结直肠癌中的表达及其作为预后生物标志物的价值。
Med Sci Monit. 2018 May 7;24:2864-2872. doi: 10.12659/MSM.910109.
6
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.结直肠癌:基因异常、肿瘤进展、肿瘤异质性、克隆进化与肿瘤起始细胞
Med Sci (Basel). 2018 Apr 13;6(2):31. doi: 10.3390/medsci6020031.
7
Therapeutic antibodies against cancer stem cells: a promising approach.针对癌症干细胞的治疗性抗体:一种有前景的方法。
Cancer Immunol Immunother. 2017 Nov;66(11):1383-1398. doi: 10.1007/s00262-017-2049-0. Epub 2017 Aug 24.
8
Cancer stem cells in human digestive tract malignancies.人类消化道恶性肿瘤中的癌症干细胞
Tumour Biol. 2016 Jan;37(1):7-21. doi: 10.1007/s13277-015-4155-y. Epub 2015 Oct 7.
9
Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.全基因组拷贝数变化和CD133表达特征化了结肠息肉的不同亚组:偶然息肉与癌症相关息肉之间的区分。
Int J Colorectal Dis. 2015 Dec;30(12):1617-26. doi: 10.1007/s00384-015-2319-2. Epub 2015 Jul 24.
10
Prognostic value of CD133 expression in cancer patients treated with chemoradiotherapy: a meta-analysis.CD133表达在接受放化疗的癌症患者中的预后价值:一项荟萃分析。
Tumour Biol. 2015 Feb;36(2):701-9. doi: 10.1007/s13277-014-2251-z. Epub 2014 Oct 7.